Wells Fargo & Company MN Acquires 6,521 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Wells Fargo & Company MN boosted its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 11.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66,028 shares of the company’s stock after acquiring an additional 6,521 shares during the quarter. Wells Fargo & Company MN owned 0.08% of Pediatrix Medical Group worth $866,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Trexquant Investment LP raised its holdings in Pediatrix Medical Group by 112.0% during the fourth quarter. Trexquant Investment LP now owns 431,230 shares of the company’s stock worth $5,658,000 after buying an additional 227,825 shares during the last quarter. Geode Capital Management LLC raised its holdings in Pediatrix Medical Group by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company’s stock worth $25,562,000 after buying an additional 11,045 shares during the last quarter. O Shaughnessy Asset Management LLC acquired a new position in Pediatrix Medical Group during the fourth quarter worth $242,000. Pictet Asset Management Holding SA raised its holdings in Pediatrix Medical Group by 63.7% during the fourth quarter. Pictet Asset Management Holding SA now owns 14,590 shares of the company’s stock worth $191,000 after buying an additional 5,677 shares during the last quarter. Finally, Nomura Asset Management Co. Ltd. raised its holdings in Pediatrix Medical Group by 95.3% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after buying an additional 1,220 shares during the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Up 2.9 %

MD opened at $12.92 on Thursday. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. The firm has a 50 day moving average price of $13.86 and a 200-day moving average price of $13.97. Pediatrix Medical Group, Inc. has a twelve month low of $6.62 and a twelve month high of $17.67. The stock has a market capitalization of $1.11 billion, a price-to-earnings ratio of -10.77, a PEG ratio of 1.74 and a beta of 1.32.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Equities research analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on MD. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 22nd. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a report on Friday, February 21st. Finally, Truist Financial decreased their price target on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, April 11th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.